Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Targeting the AhR pathway may help treat alopecia areata.

Researchers found a new mutation in the HR gene causing hair loss and skin bumps in a Pakistani family.

Vitamin D receptor gene changes don't affect alopecia areata risk.

New and known mutations in the hairless gene cause a hair loss condition called Atrichia with papular lesions.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Alopecia patients have a higher risk of heart disease.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Lower Paraoxonase 1 levels in alopecia areata patients suggest antioxidant treatment might help.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Aromatase gene variation may increase female hair loss risk.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Low PON1 levels may indicate and predict the severity of hair loss.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Human hair contains a substance that shows blood group A activity.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Mutations in the AP1B1 gene cause a new syndrome with skin, hearing, and developmental issues.

Belatacept may be a promising treatment for alopecia areata.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Certain gene variations may increase the risk and severity of alopecia areata.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Certain variations in the vitamin D receptor gene are linked to an increased risk of polycystic ovary syndrome.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.